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Tobacco Use Dependence and Approaches to Treatment  
Audrey Darville 
Chizimuzo Okoli, PhD, MPH, RN 
Tobacco Use is Considered a Global Epidemic:  
causing 5.4 million deaths per year, or 1 
person dying every 6 seconds. 
Tobacco use is increasing worldwide, and this figure is expected to reach 8 
million deaths per year by 2030. 
For every person who dies of a smoking related 
illness, 20 people develop a tobacco related disease. 
Every Day 
3,000 children and adolescents in the U.S. 
become regular tobacco users and almost half 
of the world’s children regularly breathe air 
polluted by tobacco smoke. 
Smoking in Kentucky 
Young adults (18-24) are the largest percentage of 
smokers:  38.1% 
40.5% of persons without a high school education 
smoke. 
Nearly 10% of Middle School student smoke compared 
to 6% nationally. 
A startling 26.8% of High School Students smoke 
compared to 19.7% nationally 
Past Month Cigarette Use among 
Persons Aged 12 or Older, by Age: 2006 
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Source: National Survey on Drug Use and Health, SAMHSA 
Smoking: An Expensive Habit 
• Smoking one pack a day results in spending over $1,380 
per year on cigarettes  
• The CDC estimates that the average smoker costs an 
employer $3400 per year in smoking-attributed lost 
productivity and direct medical costs  
• The real cost of smoking is about $40 per pack 
• Low income persons are more likely to smoke 
• Costs of programs like Medicaid and Medicare are 
increased 
 
Financial costs of smoking are passed 
along to nonsmokers: 
Tobacco related illness costs each household 
in Kentucky nearly $600 per year. 
Cessation Programs:  A Bargain! 
• Cost for a comprehensive smoking cessation benefit 
(medication and counseling) is $2.80 per Kentuckian per 
year, or 2 -45¢ per member per month (PMPM) (2006) 
 
• Medication alone for diabetes, hypertension, and 
depression ranged from $3.41 to $7.95 PMPM 
The Problem 
• Tobacco dependence is not “just a habit”; it’s a chronic 
disease with devastating health effects Fiore, et al (2008) Clinical Practice Guidelines 
 
• Controlling for confounders, over half a million people die 
annually in the US from tobacco related causes that could 
have been prevented Rostron (2011), Epidemiology 
 
• Even exposure to small amounts of direct or indirect tobacco 
smoke increase risk of CV mortality, the relationship is not 
linear Pope, et al (2009), Circulation 
The Solution 
 
States with aggressive tobacco control policies 
and funding for treatment programs have 
significantly reduced tobacco use in their 
populations. 
 
“Trifecta” of Controlling the Tobacco 
Epidemic    
• Access to evidence based cessation treatment 
 
• Increasing the cost of tobacco products and limiting 
access, particularly to youth 
 
• Providing tobacco free environments which make not 
smoking the easy choice 
The Tobacco Industry wants us to 
believe tobacco use is a personal choice 
Kentucky’s Tobacco Control Spending vs. 
Tobacco Industry’s Marketing Spending 
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We know: 
 
70% of smokers want to quit. 
 
30% of ever smokers in Kentucky HAVE quit. 
 
50% of Kentucky smokers have quit for at least 1 
day. 
 
 
 
 
Strong Evidence Tells Us Treatment 
Works! 
• Tobacco use is more than a habit or individual weakness 
 
• Effective treatment which is individually tailored and 
targeted is most effective 
 
• Anticipating and planning for relapse is important 
 
• Controlling tobacco exposure is critical:  it takes more 
than just “willpower” to quit 
 
Cigarettes contain over 4000 chemicals.  Of these, many are known cancer causing agents. In 1972, a spokesman for Phillip Morris said: “…if our product is harmful, we’ll stop making it.” 
Philip Morris on Nicotine…. 
  
 “Think of the cigarette pack as a storage container 
for a day’s supply of nicotine…. 
 Think of the cigarette as a dispenser for a unit dose 
of nicotine… 
 Think of a puff of smoke as a vehicle of nicotine… 
 
 Smoke is beyond question the most optimized 
vehicle of nicotine  and the cigarette the most 
optimized dispenser of smoke.” 
     
   Dr. William Dunn; Philip Morris Tobacco Company, 1972. 
 
Source: U.S. Food and Drug Administration, 1996. 
 
 
ACCP Tobacco-Dependence Treatment Tool 
Kit, 3rd Edition Slides Prepared by Gary A Giovino, PhD, MS 18 
Nicotine addiction is a major component of continued tobacco use.  Quitting is hard, and over 95% of unassisted quit attempts fail.  Staying quit is just as hard or harder than quitting. 
Known Pathways of Addiction 
Quitting is a Process 
• Most tobacco users try to quit multiple times 
 
• Motivational counseling can help all tobacco users, even 
those “not ready” to quit 
 
• Practical plans that are tailored to the individual and 
recognizes potential barriers to quit & triggers for 
smoking work best 
 
• Plans to prevent are an important to help tobacco users 
stay quit 
 
Components of Effective Addiction 
Counseling 
• Promoting Motivation to Quit: 
  Develop discrepancies between current behavior 
and desired behavior 
  “Decisional Balance” 
 
• Promoting Confidence to quit: 
  Develop a plan and useful tools (including 
medication) to assist in changing behavior 
  “Building Self-Efficacy” 
 
Counseling Demonstrates a Dose-
Response Effect/Comes in Many Forms 
• Brief advice during a “window of opportunity” can 
increase quit attempts by 40% 
 
• Medication combined with counseling doubles the 
success rate  
 
• Quitlines: proactive fax to quitline most effective 
 
• Online (becomeanex.org, smokefree.gov, mylastdip.com) 
 
• Cooper Clayton Classes at many local health departments; 
schedules and provision of medication varies 
 
• I-Phone apps/text to quit 
Medication Options: 
 Nicotine replacement therapy:  patches, gum, lozenges, 
“inhalers” (nicotine is actually deposited in the oral cavity, 
not the lungs), nasal spray.  Patches, gum and lozenges are 
available over the counter without a prescription 
 
 Bupropion* (Zyban, Wellbutrin): contraindicated for those 
with history of seizures 
 
 Varenicline* (Chantix): monitor for side effects (high 
incidence of nausea) 
 
*Both carry a “Black Box Warning” for risk of neuropsychiatric symptoms and suicidality 
 
Tailoring NRT to the tobacco user 
• Studies show efficacy in smokers and smokeless tobacco 
users (Ebbert, et al, 2010) 
 
• Combining patch with shorter acting form of NRT has 
been shown to be safe and effective (Stead, et al, Cochrane Review, 
2008; Kozlowski, et al, 2007) 
 
• Extended use of NRT or other medications is being 
shown to reduce relapse rates (Schnoll, et al, 2010) 
 
• High dose NRT is safe and effective for heavy smokers 
(Fredrickson, et al, 1995) 
From:  McNeil, et al, 2010 
Zyban (bupropion SR): 
• Adjustable dosing:  Usually 150 mg in AM first 3-5 days, 
then 150 bid, last dose with supper helps minimize 
insomnia 
 
• Has been shown to be effective used once daily with 
NRT 
 
• Contraindicated with history of seizures 
 
• Carries black box warning regarding neuropsychiatric 
symptoms/suicide risk 
 
• Available generic; coverage/cost varies 
Chantix (varenicline): 
• Titrated dosing: begin with starter pack then continuation 
pack (1 mg. bid) for 14 weeks…or more 
 
• Nausea (up to 30%) and vivid dreams most common side 
effects; can be helped with slower titration of dose 
 
• Carries Black Box warning about serious neuropsychiatric 
symptoms 
 
• Most expensive option; available on KY Medicaid, State health 
plan, PAP 
 
From:  McNeil, et al, 2010 
 
Medication Caveats 
• Nicotine replacement is a safe and effective treatment 
for tobacco dependence 
 
• Varenicline is probably most effective for promoting 
long-term abstinence 
 
• Safety concerns with varenicline and bupropion have 
been raised and should be considered 
 
• Remember smoking causes the greatest harm 
Special Populations 
• Adolescents -NRT not recommended by US 
Clinical guidelines 
 
• Those with substance use and psychiatric 
disorders- May need more intensive treatment 
(longer duration, more medication) 
 
• Pregnant and breast feeding women -NRT can 
be teratogenic 
 
 
Tobacco Free Policies and smoking 
cessation 
• Protect smokers and non-smokers alike from the KNOWN 
harmful effects of tobacco smoke 
 
• Shown to reduce smoking prevalence 
 
• Help quitters stay quit 
 
• Encourage cessation by increasing awareness of 
resources and decreasing social acceptability of smoking 
over time 
